Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

302 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma.
Arend RC, Londoño AI, Montgomery AM, Smith HJ, Dobbin ZC, Katre AA, Martinez A, Yang ES, Alvarez RD, Huh WK, Bevis KS, Straughn JM Jr, Estes JM, Novak L, Crossman DK, Cooper SJ, Landen CN, Leath CA 3rd. Arend RC, et al. Among authors: alvarez rd. Mol Cancer Res. 2018 May;16(5):813-824. doi: 10.1158/1541-7786.MCR-17-0594. Epub 2018 Mar 9. Mol Cancer Res. 2018. PMID: 29523763 Free PMC article.
Stem cell pathways contribute to clinical chemoresistance in ovarian cancer.
Steg AD, Bevis KS, Katre AA, Ziebarth A, Dobbin ZC, Alvarez RD, Zhang K, Conner M, Landen CN. Steg AD, et al. Among authors: alvarez rd. Clin Cancer Res. 2012 Feb 1;18(3):869-81. doi: 10.1158/1078-0432.CCR-11-2188. Epub 2011 Dec 5. Clin Cancer Res. 2012. PMID: 22142828 Free PMC article.
Smoothened antagonists reverse taxane resistance in ovarian cancer.
Steg AD, Katre AA, Bevis KS, Ziebarth A, Dobbin ZC, Shah MM, Alvarez RD, Landen CN. Steg AD, et al. Among authors: alvarez rd. Mol Cancer Ther. 2012 Jul;11(7):1587-97. doi: 10.1158/1535-7163.MCT-11-1058. Epub 2012 May 2. Mol Cancer Ther. 2012. PMID: 22553355 Free PMC article.
Detection of somatic TP53 mutations in tampons of patients with high-grade serous ovarian cancer.
Erickson BK, Kinde I, Dobbin ZC, Wang Y, Martin JY, Alvarez RD, Conner MG, Huh WK, Roden RBS, Kinzler KW, Papadopoulos N, Vogelstein B, Diaz LA Jr, Landen CN Jr. Erickson BK, et al. Among authors: alvarez rd. Obstet Gynecol. 2014 Nov;124(5):881-885. doi: 10.1097/AOG.0000000000000484. Obstet Gynecol. 2014. PMID: 25437714 Free PMC article. Clinical Trial.
Immunotherapy of ovarian cancer.
Kirby TO, Huh W, Alvarez R. Kirby TO, et al. Expert Opin Biol Ther. 2002 Apr;2(4):409-17. doi: 10.1517/14712598.2.4.409. Expert Opin Biol Ther. 2002. PMID: 11955278 Review.
Gene therapy.
Huh WK, Barnes MN, Kelley FJ, Alvarez RD. Huh WK, et al. Among authors: alvarez rd. Cancer Treat Res. 2002;107:133-57. doi: 10.1007/978-1-4757-3587-1_6. Cancer Treat Res. 2002. PMID: 11775448 Review. No abstract available.
302 results